Developing a Potential Treatment for Liver Failure

Current approaches to liver implantation require life-long immunosuppression. The advent of expanding liver cells (known as hepatocytes) to treat liver failure using donated liver organs or stem cells which function like liver cells would be greatly enhanced if both donated livers and/or life-long immunosuppression could be eliminated. iTOL-201 is a combination of iTOL-100 together with hepatocytes to potentially treat liver failure without the need for life-long immunosuppression.